ジーエヌアイグループの株価時系列
日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
---|---|---|---|---|---|---|---|
2024/09/17 | 2,499 | 2,531 | 2,349 | 2,435 | -60 | -2.4% | 1,778,800 |
2024/09/13 | 2,455 | 2,571 | 2,405 | 2,495 | +232 | +10.3% | 4,486,100 |
2024/09/12 | 2,218 | 2,284 | 2,193 | 2,263 | +120 | +5.6% | 1,366,500 |
2024/09/11 | 2,228 | 2,237 | 2,111 | 2,143 | -84 | -3.8% | 1,129,900 |
2024/09/10 | 2,149 | 2,260 | 2,114 | 2,227 | +111 | +5.2% | 926,100 |
2024/09/09 | 2,016 | 2,151 | 2,001 | 2,116 | +21 | +1% | 1,147,900 |
2024/09/06 | 2,140 | 2,148 | 2,078 | 2,095 | -47 | -2.2% | 861,100 |
2024/09/05 | 2,058 | 2,160 | 2,058 | 2,142 | +60 | +2.9% | 1,191,400 |
2024/09/04 | 2,097 | 2,141 | 2,042 | 2,082 | -148 | -6.6% | 1,772,800 |
2024/09/03 | 2,245 | 2,299 | 2,171 | 2,230 | -17 | -0.8% | 1,422,800 |
2024/09/02 | 2,320 | 2,333 | 2,238 | 2,247 | -42 | -1.8% | 1,369,400 |
2024/08/30 | 2,331 | 2,358 | 2,239 | 2,289 | -46 | -2% | 1,989,100 |
2024/08/29 | 2,250 | 2,449 | 2,184 | 2,335 | +95 | +4.2% | 4,058,600 |
2024/08/28 | 2,379 | 2,420 | 2,202 | 2,240 | -206 | -8.4% | 3,462,900 |
2024/08/27 | 2,240 | 2,459 | 2,202 | 2,446 | +205 | +9.1% | 3,479,600 |
2024/08/26 | 2,153 | 2,288 | 2,094 | 2,241 | +318 | +16.5% | 3,902,900 |
2024/08/23 | 1,818 | 1,924 | 1,816 | 1,923 | +94 | +5.1% | 801,800 |
2024/08/22 | 1,870 | 1,878 | 1,813 | 1,829 | -16 | -0.9% | 621,200 |
2024/08/21 | 1,834 | 1,879 | 1,810 | 1,845 | -29 | -1.5% | 748,800 |
2024/08/20 | 1,914 | 1,914 | 1,831 | 1,874 | +18 | +1% | 889,600 |
2024/08/19 | 1,870 | 1,960 | 1,834 | 1,856 | +6 | +0.3% | 1,513,600 |
2024/08/16 | 1,795 | 1,852 | 1,757 | 1,850 | +95 | +5.4% | 1,641,800 |
2024/08/15 | 1,859 | 1,870 | 1,672 | 1,755 | -176 | -9.1% | 3,659,900 |
2024/08/14 | 1,861 | 1,948 | 1,853 | 1,931 | +50 | +2.7% | 1,139,200 |
2024/08/13 | 1,868 | 1,905 | 1,833 | 1,881 | +43 | +2.3% | 867,100 |
2024/08/09 | 1,877 | 1,910 | 1,786 | 1,838 | -3 | -0.2% | 1,260,500 |
2024/08/08 | 1,719 | 1,869 | 1,716 | 1,841 | +109 | +6.3% | 1,393,900 |
2024/08/07 | 1,602 | 1,788 | 1,570 | 1,732 | +90 | +5.5% | 1,675,800 |
2024/08/06 | 1,640 | 1,695 | 1,537 | 1,642 | +98 | +6.3% | 2,702,900 |
2024/08/05 | 1,717 | 1,728 | 1,544 | 1,544 | -400 | -20.6% | 2,990,800 |
2024/08/02 | 2,133 | 2,158 | 1,941 | 1,944 | -271 | -12.2% | 1,962,800 |
2024/08/01 | 2,260 | 2,287 | 2,205 | 2,215 | -79 | -3.4% | 685,300 |
2024/07/31 | 2,342 | 2,361 | 2,267 | 2,294 | -98 | -4.1% | 806,900 |
2024/07/30 | 2,410 | 2,429 | 2,321 | 2,392 | -18 | -0.7% | 645,500 |
2024/07/29 | 2,310 | 2,410 | 2,310 | 2,410 | +130 | +5.7% | 587,900 |
2024/07/26 | 2,214 | 2,321 | 2,214 | 2,280 | +73 | +3.3% | 741,600 |
2024/07/25 | 2,191 | 2,249 | 2,180 | 2,207 | -26 | -1.2% | 654,100 |
2024/07/24 | 2,272 | 2,332 | 2,232 | 2,233 | -53 | -2.3% | 666,300 |
2024/07/23 | 2,295 | 2,314 | 2,218 | 2,286 | +8 | +0.4% | 889,100 |
2024/07/22 | 2,410 | 2,424 | 2,273 | 2,278 | -157 | -6.4% | 1,289,000 |
2024/07/19 | 2,571 | 2,594 | 2,433 | 2,435 | -156 | -6% | 1,065,600 |
2024/07/18 | 2,665 | 2,710 | 2,510 | 2,591 | -92 | -3.4% | 1,823,600 |
2024/07/17 | 2,633 | 2,703 | 2,623 | 2,683 | +125 | +4.9% | 1,011,900 |
2024/07/16 | 2,584 | 2,609 | 2,555 | 2,558 | +21 | +0.8% | 773,300 |
2024/07/12 | 2,441 | 2,554 | 2,438 | 2,537 | +96 | +3.9% | 848,700 |
2024/07/11 | 2,450 | 2,475 | 2,430 | 2,441 | +16 | +0.7% | 492,200 |
2024/07/10 | 2,454 | 2,457 | 2,365 | 2,425 | -21 | -0.9% | 667,900 |
2024/07/09 | 2,470 | 2,507 | 2,431 | 2,446 | -20 | -0.8% | 746,700 |
2024/07/08 | 2,464 | 2,468 | 2,397 | 2,466 | +30 | +1.2% | 460,300 |
2024/07/05 | 2,385 | 2,453 | 2,348 | 2,436 | +57 | +2.4% | 648,800 |
151~
200
件表示中 / 3691件
類似銘柄と比較する
現在ご覧いただいている「ジーエヌアイ」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
---|---|---|---|---|---|---|---|---|
ジーエヌアイ | 237,900円 | +21.7% | +999.9% | 0.00% | 9.90倍 | 3.27倍 |
|
中国の特発性肺線維症で高シェア、肺線維症後続薬進出。米国で人工骨も。米中に研究開発機能 |
東和薬品 | 265,700円 | +15.0% | -7.3% | 2.63% | 8.72倍 | 0.82倍 |
|
後発医薬品メーカーで国内2強の一角。循環器系に強い。直販軸に発展も卸との取引を拡大中 |
ゼリア新薬 | 233,600円 | +14.2% | +41.0% | 1.97% | 11.44倍 | 1.16倍 |
|
製薬中堅。医療用は消化器系中心。滋養強壮剤「ヘパリーゼ」も柱。スイス企業買収で海外展開 |
持田薬 | 312,000円 | +3.0% | +27.5% | 2.56% | 19.75倍 | 0.86倍 |
|
医薬中堅。高脂血症薬、降圧薬など循環器系得意。婦人科系にも強み。消化器系育成。化粧品も |
杏林製薬 | 148,000円 | +8.8% | +99.9% | 3.51% | 9.45倍 | 0.65倍 |
|
医薬中堅。柱のぜんそく薬、呼吸器アレルギー薬は下期に比重。消化器領域育成。後発品も |
市場注目の銘柄
チャート関連のコラム